CRVO 25 year old man - Factor V Leiden Heterozygous
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 447 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 360 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 419 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 360 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 392 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 368 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 430 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 372 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 379 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 360 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 366 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 368 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 378 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 357 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 379 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 365 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 344 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 386 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 367 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 323 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 342 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 379 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 372 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 403 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|

CRVO 25 year old man - Heterozygous Factor V Leidenvu 349 fois20/100 initial vision. Improved to 20/30 with Lucentis which continued for 3 years, treat and extend, and stopped.     (0 votes)
|
|
|
|
|
|
|
25 year old man with 1 week vision loss 20/16 OD 20/100 OS - CRVO
Heterozyrous for Factor V Leiden - Required 3 years of Lucentis - VA improved to 20/30. Able to stop therapy